A preliminary clinical trial of rifampicin in leprosy.
A single dose of 1500 mg. of rifampicin failed to make the lepromatous leprosy patients non-infective by using mouse foot-pad technique. It is essential to extend the trial further.
D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D012293:Rifampin / Q000627:therapeutic use*
D012293:Rifampin